analytics_image
\
Vantage Market Research
Vantage Market Research

Reports - Non-Invasive Blood Glucose Monitoring Systems Market

iconHealthcare

Non-Invasive Blood Glucose Monitoring Systems Market

Non-Invasive Blood Glucose Monitoring Systems Market Valuation and Growth Forecast 2025-2035 by Technology (Spectroscopy, Electromagnetic, Microwave, Ultrasonic, Thermal, Others) by End Users (Hospitals, Homecare, Clinics) by Modality (Wearable, Non-wearable) by Distribution Channel (Retail Sales, Institutional Sales) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa

ppt icon
pdf icon
xlsx icon
power bi icon
immediate delivery icon

Industry Leaders Trust Us For Actionable Intelligence

Revenue Insights

Market Size in 2024

USD 33.9 Million

Market Size By 2035

USD 284.43 Million

CAGR (2025 - 2035)

21.3%

Largest Region

North America

Fastest Region

Europe

Base Year

2024

Historic Data

2021 - 2023

Forecast Period

2025 - 2035

Segments Covered

By Technology, By End Users, By Modality, By Distribution Channel, By Region

Report Coverage

The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.

Overview

The global Non-Invasive Blood Glucose Monitoring Systems Market is valued at USD 33.9 Million in 2024 and is projected to reach a value of USD 284.43 Million by 2035 at a CAGR (Compound Annual Growth Rate) of 21.3% between 2025 and 2035. The market is driven by increasing demand for user-friendly and painless monitoring solutions, as well as AI integration for personalized diabetes management.

Key Highlights

  • In 2024, North America dominated the market with 53.20% market share
  • By Technology, the Spectroscopy dominated the market in 2024
  • By Distribution Channel, the Retail Sales dominated the market in 2024
  • Based on modality, the Wearable dominated the market with 56.50% market share
  • Based on End user, the Homecare dominated the market in 2024

Non-Invasive Blood Glucose Monitoring Systems Market Size, 2024 To 2035 (USD Million)

Technology Overview

The Technology Segment is divided into Spectroscopy, Electromagnetic, microwave, ultrasonic, thermal, and Others. The Spectroscopy held the dominant share in 2024.

The demand for spectroscopy technology is increasing due to the rising number of diabetes cases and related complications. This growth is expected as non-invasive procedures, which provide painless and quick monitoring solutions, become more popular. The evolution of cost-effective options will further boost market expansion during the forecast period.

Modality Overview

The Modality segment is divided into wearable and non-wearable. The wearable held the dominant share in 2024, accounting for significant market share of 56.50%.

The demand for painless, needle-free, and continuous glucose monitoring wearable sensors is a major factor driving this segment. AerBetic producers a non-invasive blood glucose monitoring that continuously provides blood sugar levels. It also comes with an application that allows a user to set up alerts in order to communicate to a network of health care providers. For instance, in June 2024, Abbott announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose monitoring (CGM) systems – Lingo™ and Libre Rio™, which are based on Abbotts world-leading FreeStyle Libre® continuous glucose monitoring technology, now used by about 6 million people globally. The newly cleared systems have been intentionally designed to meet different needs – Lingo for consumers who want to better understand and improve their health and wellness, and Libre Rio for adults with Type 2 diabetes who do not use insulin and typically manage their diabetes through lifestyle modifications.

Regional Overview

In 2024, the North America captured 53.20% of the revenue share.

North America Non-Invasive Blood Glucose Monitoring Systems market is driven by high prevalence of diseases and well-established health care infrastructure that enables proper diagnosis are attributed to the North America largest share. According to the American Diabetes Association, in 2018, 34.2 million people in the U.S., or 10.5% of the population, had diabetes. Moreover, 1.6 million people have type 1 diabetes, including about 187,000 children and adolescents.

The US held the largest market share and is anticipated to register the highest CAGR during the forecast period. The market is driven by rising prevalence of diabetes and increasing demand for painless monitoring solutions. The growing number of diabetes cases is pushing consumers to seek alternatives to traditional finger-prick methods, as non-invasive devices provide a pain-free option that enhances compliance.

In Europe, Non-Invasive Blood Glucose Monitoring Systems market is experiencing notable growth, driven by include significant technological advancements, with innovations in sensor technologies such as near-infrared spectroscopy and bioimpedance analysis, enabling accurate and painless glucose monitoring. With both established medical device manufacturers and innovative startups competing in this space, the market is expected to expand significantly as these devices become more accessible and affordable for patients across Europe.

  • Technological Advancements: Innovations in sensor technologies, such as near-infrared spectroscopy and bioimpedance analysis, are improving the accuracy and reliability of non-invasive monitoring
  • Integration with Digital Health Solutions: Many non-invasive devices are now integrated with mobile apps and digital health platforms for enhanced data tracking and management
  • Competitive Landscape: Established medical device manufacturers and innovative startups are intensifying competition, resulting in more diverse product offerings

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Market Dynamics

Rising Prevalence of Diabetes

The growing prevalence of diabetes among populations in both developed and emerging countries is leading to a large patient pool globally requiring blood monitoring, which is further resulting in increasing demand for these devices among the patient population. Market driven by including rapid urbanization and the rising shift toward a sedentary lifestyle, in emerging and developed countries are primarily responsible for the growing prevalence of diabetes. A significant increase has been observed in the number of patients suffering from type-1 or insulin-dependent type 2 diabetes, which has been instrumental in surging the uptake of blood glucose monitoring systems globally.

High Cost Associated with CGM Systems

The initial purchase price of CGM devices can be substantial, ranging from several hundred to over a thousand dollars, and sensors, which typically need replacement every 7 to 14 days, add significant ongoing expenses. Insurance coverage for CGM systems varies widely, with some plans providing limited coverage or imposing strict approval criteria, leaving patients to shoulder the financial burden. Additionally, proper use of CGM systems often requires training for both patients and healthcare providers, leading to extra costs for consultations and follow-up appointments.

Competitive Landscape

The Non-Invasive Blood Glucose Monitoring Systems market is characterized by dynamic and evolving environment with several key players and their ongoing advancement. Major Players are Abbott Laboratories, Medtronic plc, Dexcom Inc, Ascensia Diabetes Care, Sanofi Novo Nordisk, Insulet corporation, Glysens Incorporated, F.hoffman-La Roche Ltd., Taiwan Biophotonic Corporation. Companies are also forming strategic partnerships with healthcare providers and technology firms to enhance their offerings and navigate regulatory approvals. With the global rise in diabetes cases, companies are expanding geographically to capture new markets, especially by securing key regulatory approvals.

Recent Market Developments

Abbott Enters Global Partnership to Connect Its World-Leading Continuous Glucose Monitoring System with Medtronics Insulin Delivery Devices

  • In August 2024, Abbott announced a unique global partnership with Medtronic to collaborate on an integrated continuous glucose monitoring (CGM) system based on Abbotts most advanced, world-leading1 FreeStyle Libre technology that will connect with Medtronics automated insulin delivery (AID) and smart insulin pen systems

The global Non-Invasive Blood Glucose Monitoring Systems market can be categorized as Technology, End User, Modality, Distribution Channel and Region.

Market Segmentation

ParameterDetails
Segment Covered

By Technology

  • Spectroscopy
  • Electromagnetic
  • Microwave
  • Ultrasonic
  • Thermal
  • Others

By End Users

  • Hospitals
  • Homecare
  • Clinics

By Modality

  • Wearable (56.5%)
  • Non-wearable

By Distribution Channel

  • Retail Sales
  • Institutional Sales

By Region

  • North America (U.S., Canada, Mexico) (53.20%)
  • Europe (Germany, France, U.K., Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe)
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, South-East Asia, Rest of Asia Pacific)
  • Latin America (Brazil, Argentina, Rest of Latin America)
  • Middle East & Africa
Companies Covered
  • Abbott Laboratories
  • Medtronic Plc
  • Dexcom Inc
  • Ascensia Diabetes Care
  • Sanofi Novo Nordisk
  • Insulet Corporation
  • Glysens Incorporated
  • F.Hoffman-La Roche Ltd.
  • Taiwan Biophotonic Corporation
Customization ScopeEnjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data.
Pricing and purchase optionsAccess flexible purchase options tailored to your specific research requirements. Explore purchase options

Report coverage & Deliverables

Our PDF Reports And Online Dashboard
Will Help You Stay Ahead In The Market.

    Key features include:

  • Check
    Competitive benchmarking
  • Check
    Historical data and future forecasts
  • Check
    Company-wise revenue breakdown
  • Check
    Regional growth opportunities
  • Check
    Latest market trends and dynamics
  • Check
    Impact of emerging technologies like AI and automation
  • Check
    Key regulatory updates and ESG considerations

FAQ‘s

Related Reports

vantage logo

Vantage Market Research & Consultancy Services is all about providing accurate and reliable market intelligence to its clients for the seamless execution of their business growth strategies.

© 2025 Vantage Market Research. All right reserved
Secured Bysecured by
Non-Invasive Blood Glucose Monitoring Systems Market Valuation and Growth Forecast 2025-2035